Step 1: Understanding the Question:
A patient develops muscle rigidity after exposure to specific anesthetic triggers: sevoflurane (volatile gas) and succinylcholine (muscle relaxant).
This classic clinical scenario describes Malignant Hyperthermia (MH), a life-threatening pharmacogenetic condition.
Step 2: Detailed Explanation:
Pathophysiology of Malignant Hyperthermia: MH is caused by a mutation in the Ryanodine Receptor (RYR1) in skeletal muscle. Triggering agents cause an uncontrolled, massive release of calcium from the sarcoplasmic reticulum.
Clinical Manifestations: This calcium flood leads to sustained muscle contraction (rigidity), hypermetabolism, rapid rise in temperature (hyperthermia), and metabolic acidosis.
Drug of Choice: The definitive treatment for an MH crisis is Dantrolene Sodium.
Mechanism of Dantrolene: Dantrolene is a skeletal muscle relaxant that works by directly binding to the RYR1 receptor. It blocks the release of calcium from the sarcoplasmic reticulum, thereby reversing the metabolic crisis.
Management Steps: Immediate treatment includes stopping all triggers, hyperventilating with 100% oxygen, and cooling the patient alongside the administration of intravenous Dantrolene.
Why not other options? Diazepam is a CNS-acting muscle relaxant and is ineffective in MH. Propranolol and Paracetamol only treat symptoms (tachycardia and fever) but do not address the underlying intracellular calcium defect.
Step 3: Final Answer:
Dantrolene is the only specific and life-saving antidote for Malignant Hyperthermia triggered by anesthetic agents.